O. Mejia-Mejia

Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31

S. Paik, Chungyeul Kim, J. Costantino, 2007 .

Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity

R. Poppiti, T. Mesko, O. Mejia-Mejia, 2019, Journal of breast cancer.